ENDOSENSE

endosense-logo

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense's TactiCathร‚ยฎ is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. It has undergone considerable pre-clinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.

#SimilarOrganizations #People #Financial #Website #More

ENDOSENSE

Social Links:

Industry:
Biotechnology Health Care Medical Device Therapeutics

Founded:
2003-01-01

Address:
Geneva, Geneve, Switzerland

Country:
Switzerland

Website Url:
http://www.endosense.com

Total Employee:
51+

Status:
Active

Contact:
41 22 306 19 60

Email Addresses:
[email protected]

Total Funding:
141.54 M USD

Technology used in webpage:
IPv6 Cloudflare Hosting Cloudflare DNS


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.


Current Advisors List

jan-egberts_image

Jan Egberts Member of the Board of Directors @ Endosense
Board_member

michael-dormer_image

Michael Dormer Board Member @ Endosense
Board_member

patrick-van-beneden_image

Patrick Van Beneden Board Member @ Endosense
Board_member

olivier-litzka_image

Olivier Litzka Board Member @ Endosense
Board_member

diego-braguglia_image

Diego Braguglia Board Member @ Endosense
Board_member

claudio-nessi_image

Claudio Nessi Board Member @ Endosense
Board_member
2005-01-01

Founder


giovanni-leo_image

Giovanni Leo

Investors List

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Series C - Endosense

initiative-capital-romandie_image

Initiative Capital Romandie

Initiative Capital Romandie investment in Series C - Endosense

ysios-capital_image

Ysios Capital

Ysios Capital investment in Series C - Endosense

gimv_image

Gimv

Gimv investment in Series C - Endosense

vi-partners_image

VI Partners

VI Partners investment in Series C - Endosense

sectoral-asset-management_image

Sectoral Asset Management

Sectoral Asset Management investment in Series C - Endosense

neomed-management_image

Neomed Management

Neomed Management investment in Series C - Endosense

ngn-capital_image

NGN Capital

NGN Capital investment in Series C - Endosense

vi-partners_image

VI Partners

VI Partners investment in Series C - Endosense

initiative-capital_image

Initiative Capital

Initiative Capital investment in Series C - Endosense

Official Site Inspections

http://www.endosense.com

  • Host name: 166.117.110.61
  • IP address: 166.117.110.61
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Endosense"

Endosense

Looking for faster, easier, and cheaper solutions? Welcome to EndoSense, the first ever at-home, noninvasive rapid test for endometriosis. Weโ€™re working to redefine healthcare by offering a โ€ฆSee details»

Endosense - Crunchbase Company Profile & Funding

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.See details»

Endosense 2025 Company Profile: Valuation, Investors โ€ฆ

Information on acquisition, funding, cap tables, investors, and executives for Endosense. Use the PitchBook Platform to explore the full profile.See details»

Endosense - LinkedIn

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias.See details»

St. Jude Medical Acquires Endosense - innovationsincrm.com

St. Jude Medical, Inc., a global medical device company, today announced the acquisition of Endosense SA, a Switzerland-based company that has pioneered contact-force measurement โ€ฆSee details»

endosense.com

Endosense.comSee details»

Endosense - VentureRadar

Founded in Geneva in 2003, Endosense is a medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac โ€ฆSee details»

About โ€“ Endosense

The idea for EndoSense eventually came from a conversation when one of our mothers received her medical bills and was expressing how frustratingly expensive and time-consuming it was to โ€ฆSee details»

Endosense - 2025 Company Profile & Team - Tracxn

Jun 16, 2025 Endosense is an acquired company based in Meyrin (Switzerland), founded in 2003 by Giovanni Leo. It operates as a Developer of catheter ablation technology for cardiac โ€ฆSee details»

Endosense - Products, Competitors, Financials, Employees, โ€ฆ

About Endosense Endosense is a medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias. โ€ฆSee details»

Endosense - Funding, Financials, Valuation & Investors

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.See details»

Endosense Closes $40.3M Series C - venturecapitaljournal.com

Nov 27, 2012 Endosense, a developer of technology for catheter ablation for the treatment of cardiac arrhythmias, has raised $40.3 million in Series C financing. new investor NGN Capital โ€ฆSee details»

Product โ€“ Endosense

Welcome to Endosense Say goodbye to lab work, invasive surgeries, and expensive, time-consuming processes. Consisting of one multiplexed lateral flow assay for proteins and โ€ฆSee details»

Endosense | Gimv

Aug 19, 2013 Endosense was founded in 2003 in Geneva. It develops and commercialises TactiCath®, a unique catheter used for treating cardiac rhythm disorders. Catheter ablation is โ€ฆSee details»

ENDOSENSE SA - Drug pipelines, Patents, Clinical trials - Synapse

Explore ENDOSENSE SA with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news.See details»

Endosense closes CHF 37.4 million series C round

Nov 27, 2013 Endosense, a Swiss medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias โ€ฆSee details»

Endosense Closes USD 36 Million / Euro 25 Million Series B โ€ฆ

Sep 1, 2009 Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation, has announced that it has received USD 36 โ€ฆSee details»

Endosense - Financial Details - Crunchbase

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.See details»

Endometriosis โ€“ Endosense

Weโ€™re dedicated to scientific excellence, tackling the pressing challenges of our time, and shaping the future with groundbreaking research.See details»

Endosense - Profiles & Contacts - Crunchbase

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.See details»

linkstock.net © 2022. All rights reserved